PJ

Active Director Director DIN 01822133
DIN 01822133 First appointment Feb 2006 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Paul John

Data last updated:

Paul John is a Director at Cnidus Pharma Private Limited (since 2006). The company operates in Chemicals.

DIN 01822133
Primary Designation Director
Industry Chemicals
First Appointment 14 Feb 2006
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cnidus Pharma Private Limited U24232KL2006PTC019188
Director14 Feb 20062006Active

Directorship timeline

Open interactive timeline →
Cnidus Pharma Private Limited
Premium access

Shareholding and investment profile for Paul John

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paul John

Paul John currently holds 1 directorship: Cnidus Pharma Private Limited (Director, since 14 Feb 2006).

Paul John was first appointed on 14 Feb 2006 as Director at Cnidus Pharma Private Limited.

The current boards of Paul John's companies include Chacko Mathai Mattathil (Cnidus Pharma Private Limited), Francis Thomas (Cnidus Pharma Private Limited), George Jacob (Cnidus Pharma Private Limited), George John (Cnidus Pharma Private Limited), George Joseph Mookken (Cnidus Pharma Private Limited), Jeena George (Cnidus Pharma Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available